| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $8.16B | +3.0% |
| Cost of Revenue | $5.82B | +3.6% |
| Gross Profit | $2.34B | +1.5% |
| R&D Expense | $31.9M | +10.0% |
| SG&A Expense | $1.31B | -1.6% |
| Operating Income | $799.3M | +0.7% |
| Interest Expense | $361.4M | +14.2% |
| Pre-tax Income | $444.0M | -6.0% |
| Income Tax | $108.7M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $176.7M | -77.6% |
| Accounts Receivable | $735.4M | +26.2% |
| Inventory | $875.0M | +16.0% |
| Current Assets | $2.02B | -9.3% |
| Total Assets | $13.53B | +5.2% |
| Current Liabilities | $1.21B | +28.4% |
| Long-term Debt | $7.42B | +9.0% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $998.3M | +7.1% |
| Investing Cash Flow | -$1.42B | -109.5% |
| Financing Cash Flow | -$188.6M | -145.4% |
| +3.4% |
| Net Income | $335.7M | -8.5% |
| EPS (Basic) | $5.98 | -2.3% |
| EPS (Diluted) | $5.51 | -2.3% |
| Total Liabilities |
| $9.76B |
| +11.6% |
| Stockholders' Equity | $3.75B | -8.3% |